跳至主要内容
临床试验/NCT00336076
NCT00336076已完成不适用

Investigation of Cellular and Molecular Pathologic Mechanisms in Mast Cell Disorders.

University of Michigan1 个研究点 分布在 1 个国家目标入组 136 人开始时间: 2004年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
136
试验地点
1
主要终点
Proportion of the patients with clonal and non-clonal mast cell disorders

研究概览

简要总结

Mastocytosis is a disorder characterized by presence of excessive numbers of mast cells in skin, bone marrow and internal organs. It can affect both children and adults, males and females and individuals from all ethnic backgrounds, although precise demographic information about the affected populations is not available as it is a rare disorder. Mastocytosis in children is generally limited to the skin and follows a self limited course, while it is a disorder of the hematopoietic stem cell associated with somatic mutations of the c-kit gene in most patients with adult-onset of disease. There is no known curative therapy for most patients with systemic mastocytosis. Recent research studies identified several subtypes of disease with distinct clinical and pathologic features, however, a precise understanding of the incidence as well as molecular pathology of different disease subtypes is lacking. This study aims to examine molecular and cellular pathological aspects of disease in patients with mastocytosis and correlate findings with clinical presentation and prognosis. Patients will undergo a routine history and physical examination, and diagnostic tests will be ordered as dictated by each patient's clinical presentation. Blood and bone marrow will be obtained for diagnostic and research purposes. Genetic analysis of the c-kit gene regulating mast cell growth and differentiation will be performed. It is hoped that findings obtained from this study will help to design novel therapies for mastocytosis and other disorders in which mast cells play a critical role.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Confirmed or suspected diagnosis of mastocytosis.
  • Ability to give informed consent (by the patient or legal guardian if minor)

排除标准

  • Inability or not willing to provide informed consent.

结局指标

主要结局

Proportion of the patients with clonal and non-clonal mast cell disorders

时间窗: 1 week

Patients were categorized into one of the clonal and non-clonal mast cell disorder categories after availability of diagnostic data

次要结局

  • Proportion of KIT D816V mutation in blood, bone marrow and sorted mast cells(1 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Cem Akin

Assistant Professor

University of Michigan

研究点 (1)

Loading locations...

相似试验